This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2002
Title: Jay Cunningham: Innovator in Chemotherapeutic Advancements
Introduction
Jay Cunningham is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for cancer. His work focuses on enhancing the efficacy of chemotherapeutic agents through novel approaches.
Latest Patents
Cunningham holds a patent for his invention titled "αnβ3 integrin antagonists in combination with chemotherapeutic agents." This patent represents a critical advancement in cancer treatment, aiming to improve patient outcomes by combining targeted therapies with traditional chemotherapy. He has 1 patent to his name, showcasing his commitment to innovation in the medical field.
Career Highlights
Throughout his career, Jay Cunningham has demonstrated a strong dedication to research and development. His work has been instrumental in exploring new therapeutic avenues that can potentially transform cancer treatment protocols. His innovative mindset and scientific expertise have positioned him as a valuable contributor to the medical community.
Collaborations
Cunningham has collaborated with esteemed colleagues, including Gary B. Gordon and G. Allen Nickols. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.
Conclusion
Jay Cunningham's contributions to the field of cancer treatment through his innovative patent highlight his role as a leading inventor. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile